Search results for "Musculoskeletal disease"

showing 10 items of 844 documents

Immediate effects of active versus passive scapular correction on pain and pressure pain threshold in patients with chronic neck pain.

2012

OBJECTIVE: The purpose of this study was to investigate the effect of active vs passive scapular correction on pain and pressure pain threshold at the most symptomatic cervical segment in patients with chronic neck pain. METHODS: Twenty-three volunteers with chronic, idiopathic neck pain were recruited (age, 38.9 ± 14.4 years; sex [man/woman], 3/20; Neck Disability Index, 28.1% ± 9.9%). Subjects were randomly allocated to 2 groups: active scapular correction or passive scapular correction. Pressure pain threshold and pain intensity rated on a numerical rating scale during a posteroanterior glide over the most symptomatic cervical segment were measured before and immediately after the active…

MalePressure painSeverity of Illness Indexlaw.inventionMagnetic Resonance Imaging/methodsRandomized controlled trialScapulalawManipulation Spinal/methodsYoung adultPain MeasurementNeck painBrain MappingNeck PainPain Perception/physiologyManipulation ChiropracticNeck Pain/diagnosisPain PerceptionMotion Therapy Continuous Passive/methodsmusculoskeletal systemMagnetic Resonance ImagingManipulation Chiropractic/methodsScapulaTreatment OutcomePatient SatisfactionManipulation OrthopedicFemalemedicine.symptomChronic PainChronic Pain/diagnosismusculoskeletal diseasesAdultManipulation SpinalPain Thresholdmedicine.medical_specialtyAdolescentYoung AdultSeverity of illnessmedicinePressureHumansIn patientManipulation Orthopedic/methodsPain Threshold/physiologyReferred painbusiness.industryMotion Therapy Continuous PassiveSurgeryPatient Satisfaction/statistics & numerical dataChiropracticsbusinessFollow-Up StudiesJournal of manipulative and physiological therapeutics
researchProduct

Prevention of Tungiasis and Tungiasis-Associated Morbidity Using the Plant-Based Repellent Zanzarin: A Randomized, Controlled Field Study in Rural Ma…

2013

Background Tungiasis, a parasitic skin disease caused by the female sand flea Tunga penetrans, is a prevalent condition in impoverished communities in the tropics. In this setting, the ectoparasitosis is associated with important morbidity. It causes disfigurement and mutilation of the feet. Feasible and effective treatment is not available. So far prevention is the only means to control tungiasis-associated morbidity. Methodology In two villages in Central Madagascar, we assessed the efficacy of the availability of closed shoes and the twice-daily application of a plant-based repellent active against sand fleas (Zanzarin) in comparison to a control group without intervention. The study pop…

MaleRural PopulationFleaAttack ratemedicine.disease_causeSeverity of Illness IndexPantothenic Acidlaw.inventionToxicologyRandomized controlled triallawPrevalenceTungaChildAged 80 and overbiologylcsh:Public aspects of medicineMiddle AgedInfectious DiseasesTreatment OutcomeChild PreschoolPopulation studyFemaleResearch Articlemusculoskeletal diseasesAdultmedicine.medical_specialtylcsh:Arctic medicine. Tropical medicineAdolescentlcsh:RC955-962Tunga penetransYoung AdultInfestationparasitic diseasesmedicineMadagascarAnimalsHumansPlant OilsAgedIntention-to-treat analysisbusiness.industryPlant ExtractsPublic Health Environmental and Occupational Healthlcsh:RA1-1270biology.organism_classificationmedicine.diseaseSurgeryInsect RepellentsTungiasisTungiasisbusinessPLoS Neglected Tropical Diseases
researchProduct

The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cros…

2011

Import JabRef | WosArea Orthopedics; Rheumatology; International audience; Objective: To assess the pain and functional disability levels corresponding to an indication for total joint replacement (TJR) in hip and knee osteoarthritis (OA). Methods: Design: International cross-sectional study in 10 countries. Patients: Consecutive outpatients with definite hip or knee OA attending an orthopaedic outpatient clinic. Gold standard measure for recommendation for TJR: Surgeon's decision that TJR is justified. Outcome measures: Pain (ICOAP: intermittent and constant osteoarthritis pain, 0-100) and functional impairment (HOOS-PS/KOOS-PS: Hip/Knee injury and Osteoarthritis Outcome Score Physical fun…

MaleSURGERYmedicine.medical_treatmentArthroplasty Replacement HipOsteoarthritisSeverity of Illness IndexOsteoarthritis HipRADIOGRAPHIC FEATURESDisability Evaluation0302 clinical medicineMedicineOutpatient clinicOrthopedics and Sports Medicine030212 general & internal medicinePREDICTORSArthroplasty Replacement KneePain Measurement/methodsPain/diagnosisPain Measurementddc:616ASSOCIATIONOsteoarthritis KneeMiddle Aged3. Good healthPRIORITIZATIONTRIALS[ SCCO.NEUR ] Cognitive science/NeuroscienceFemaleOsteoarthritis Hip/physiopathology/surgerymusculoskeletal diseasesmedicine.medical_specialtyJoint replacementSymptomDecision MakingBiomedical EngineeringPainArticle03 medical and health sciencesRheumatologySeverity of illnessOsteoarthritisPHYSICAL-FUNCTIONHumansKneeARTHROPLASTYRheumatology and AutoimmunityAged030203 arthritis & rheumatologyHip surgeryHipOsteoarthritis Knee/physiopathology/surgerybusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceJoint replacementGold standard[SCCO.NEUR] Cognitive science/NeuroscienceOUTCOME MEASUREKnee Hip Osteoarthritis Joint replacement Surgery Symptom radiographic features physical-function outcome measure arthroplasty severity surgery trials prioritization association predictorsmedicine.diseaseArthroplastySEVERITYCross-Sectional StudiesOrthopedic surgeryPhysical therapySurgerybusiness
researchProduct

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine.

2013

Objective Obesity is a mild, long-lasting inflammatory disease and, as such, could increase the inflammatory burden of rheumatoid arthritis (RA). The study aim was to determine whether obesity represents a risk factor for a poor remission rate in RA patients requiring anti–tumor necrosis factor α (anti-TNFα) therapy for progressive and active disease despite treatment with methotrexate or other disease-modifying antirheumatic drugs. Methods Patients were identified from 15 outpatient clinics of university hospitals and hospitals in Italy taking part in the Gruppo Italiano di Studio sulle Early Arthritis network. Disease Activity Score in 28 joints (DAS28), body mass index (BMI; categorized …

MaleSettore MED/16 - REUMATOLOGIAArthritisGastroenterologyReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis RheumatoidRheumatoidMonoclonalReceptorsMedicineOutpatient clinicLongitudinal StudiesRegistriesPrecision Medicineskin and connective tissue diseasesHumanizedRemission InductionAntibodies MonoclonalIndividualized MedicineMiddle AgedTreatment OutcomeRheumatoid arthritisAntirheumatic AgentsFemaleDrugmedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyAdalimumab; Aged; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthritis Rheumatoid; Dose-Response Relationship Drug; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Longitudinal Studies; Male; Middle Aged; Obesity; Precision Medicine; Receptors Tumor Necrosis Factor; Registries; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alphaAntibodies Monoclonal HumanizedAntibodiesDose-Response RelationshipRheumatologyInternal medicineAdalimumabHumansObesityRisk factorAgedDose-Response Relationship Drugbusiness.industryTumor Necrosis Factor-alphaArthritisAdalimumabmedicine.diseaseInfliximabRheumatologyInfliximabAged; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthritis Rheumatoid; Dose-Response Relationship Drug; Female; Humans; Immunoglobulin G; Individualized Medicine; Longitudinal Studies; Male; Middle Aged; Obesity; Receptors Tumor Necrosis Factor; Registries; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alphaImmunoglobulin GImmunologybusinessTumor Necrosis FactorArthritis careresearch
researchProduct

Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.

2014

Objective.To evaluate the safety and efficacy of therapy with etanercept and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) and mild hepatitis C virus (HCV) infection.Methods.In this prospective open study, 29 patients with active RA were randomly assigned to receive therapy with MTX alone, etanercept alone, or a combination of MTX and etanercept, and monitored up to 54 weeks. The primary endpoint was safety; secondary aims were efficacy as defined by the 44-joint Disease Activity Score (DAS44) and health assessment questionnaire (HAQ). Serum liver enzymes and HCV viral load were serially measured.Results.In the whole cohort, aspartate aminotransferase (AST) serum leve…

MaleSettore MED/16 - REUMATOLOGIATNF-α INHIBITORSHEALTH ASSESSMENT QUESTIONNAIREHepacivirusmedicine.disease_causeVirus ReplicationGastroenterologySeverity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptEtanerceptArthritis RheumatoidDISEASE ACTIVITY SCORELiver Function TestsRheumatoidReceptorsImmunology and AllergyProspective StudiesGISEAbiologyAlanine TransaminaseHepatitis CMiddle AgedViral LoadHepatitis CTreatment OutcomeRheumatoid arthritisAntirheumatic AgentsCombinationDrug Therapy CombinationFemaleTRANSAMINASESViral loadmedicine.drugmusculoskeletal diseasesAdultmedicine.medical_specialtyHepatitis C virusImmunologyDrug TherapyRheumatologyInternal medicinemedicineHumansAspartate AminotransferasesAgedHepatitisbusiness.industryArthritisTNF-alpha INHIBITORS TRANSAMINASES GISEA DISEASE ACTIVITY SCORE HEALTH ASSESSMENT QUESTIONNAIREmedicine.diseaseRheumatologyMethotrexateAlanine transaminaseImmunoglobulin GImmunologybiology.proteinTumor Necrosis FactorbusinessThe Journal of rheumatology
researchProduct

"I Know that You Know that I Know": Neural Substrates Associated with Social Cognition Deficits in DM1 Patients.

2016

Myotonic dystrophy type-1 (DM1) is a genetic multi-systemic disorder involving several organs including the brain. Despite the heterogeneity of this condition, some patients with non-congenital DM1 can present with minimal cognitive impairment on formal testing but with severe difficulties in daily-living activities including social interactions. One explanation for this paradoxical mismatch can be found in patients' dysfunctional social cognition, which can be assessed in the framework of the Theory of Mind (ToM). We hypothesize here that specific disease driven abnormalities in DM1 brains may result in ToM impairments. We recruited 20 DM1 patients who underwent the "Reading the Mind in th…

MaleSocial CognitionMagnetic Resonance SpectroscopyTheory of MindAdult; Brain; Cognition; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myotonic Dystrophy; Neuropsychological Tests; Social Behavior; Theory of MindSocial Scienceslcsh:MedicineDiseaseNeuropsychological TestsDiagnostic RadiologyCognition0302 clinical medicineFunctional Magnetic Resonance ImagingTheory of mindMedicine and Health SciencesPsychologyMyotonic Dystrophylcsh:ScienceCognitive ImpairmentBrain MappingMultidisciplinarymedicine.diagnostic_testCognitive NeurologyRadiology and Imagingagricultural and biological sciences (all); biochemistry genetics and molecular biology (all); medicine (all)05 social sciencesRBrainCognitionMiddle AgedMagnetic Resonance ImagingNeurologyRC0346Genetic DiseasesPhysical SciencesFemaleSettore MED/26 - NeurologiaPsychologyResearch ArticleClinical psychologyAdultmusculoskeletal diseasesComputer and Information Sciencesmedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesSocial PsychologyImaging TechniquesCognitive NeuroscienceNeuroimagingDysfunctional familyResearch and Analysis MethodsMyotonic dystrophy050105 experimental psychology03 medical and health sciencesDiagnostic MedicineSocial cognitionTheory of mind cerebral lesionGeneticsmedicineHumans0501 psychology and cognitive sciencesSocial BehaviorPsychiatryClinical GeneticsSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicalcsh:RCognitive PsychologyBiology and Life SciencesHuman Geneticsmedicine.diseaseComprehensionGraph TheoryRC0321Cognitive Sciencelcsh:QFunctional magnetic resonance imagingMathematics030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

Combining Ergonomic Risk Assessment (RULA) with Inertial Motion Capture Technology in Dentistry—Using the Benefits from Two Worlds

2021

Traditional ergonomic risk assessment tools such as the Rapid Upper Limb Assessment (RULA) are often not sensitive enough to evaluate well-optimized work routines. An implementation of kinematic data captured by inertial sensors is applied to compare two work routines in dentistry. The surgical dental treatment was performed in two different conditions, which were recorded by means of inertial sensors (Xsens MVN Link). For this purpose, 15 (12 males/3 females) oral and maxillofacial surgeons took part in the study. Data were post processed with costume written MATLAB® routines, including a full implementation of RULA (slightly adjusted to dentistry). For an in-depth comparison, five newly i…

MaleTechnologyErgonomic riskInertial motion captureComputer sciencekinematic analysisDentistryContext (language use)TP1-1185Kinematicsdental treatment conceptwork place evaluationRisk AssessmentBiochemistryArticleAnalytical ChemistryUpper ExtremityScore distribution03 medical and health sciences0302 clinical medicineInertial measurement unitHumans0501 psychology and cognitive sciencesMusculoskeletal DiseasesElectrical and Electronic EngineeringInstrumentation050107 human factorsMaxillofacial surgeonsbusiness.industryChemical technologywearable sensorsdentist05 social sciencesWork (physics)030210 environmental & occupational healthAtomic and Molecular Physics and OpticsOccupational DiseasesergonomicsDentistryinertial motion unitsFemaledental assistantbusinesshuman factorsSensors (Basel, Switzerland)
researchProduct

Impact of periodontal treatment on the RANKL/OPG ratio in crevicular fluid.

2020

Aim Alveolar resorption is one of the most important events in periodontitis. Osteoclast activity is regulated by the ratio between receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG). The aim of this study was to evaluate changes in the RANKL/OPG ratio in crevicular fluid after periodontal treatment. Material and methods A total of 15 patients with periodontitis were included in the study group. Samples were collected from an area with active periodontitis and a healthy area. The RANKL and OPG levels were measured before and after periodontal scaling and root planing (SRP) treatment. The study group was compared to the control group, which included 10 patients without peri…

MaleTeethAlveolar Bone LossOsteoclastsPathology and Laboratory MedicineAntiplatelet TherapyVascular Medicine0302 clinical medicineScaling and root planingOral DiseasesAnimal CellsMedicine and Health SciencesProspective StudiesProspective cohort studyConnective Tissue CellsMultidisciplinarybiologyPharmaceuticsQRGingival Crevicular FluidMiddle AgedHealthy VolunteersTreatment Outcomemedicine.anatomical_structureConnective TissueRANKL030220 oncology & carcinogenesisMedicineFemaleAnatomyCellular TypesPeriodontal IndexResearch Articlemusculoskeletal diseasesmedicine.medical_specialtyScienceOral MedicineHemorrhage03 medical and health sciencesSigns and SymptomsDrug TherapyOsteoprotegerinDiagnostic MedicineOsteoclastInternal medicinemedicineHumansPeriodontitisBonePeriodontal DiseasesAgedPeriodontitisbusiness.industryRANK LigandOsteoprotegerinCase-control studyBiology and Life SciencesRANK LigandCell Biology030206 dentistrymedicine.diseaseBiological TissueEndocrinologyJawCase-Control StudiesChronic Periodontitisbiology.proteinDental ScalingbusinessDigestive SystemHeadPLoS ONE
researchProduct

Longterm Retention of Tumor Necrosis Factor-α Inhibitor Therapy in a Large Italian Cohort of Patients with Rheumatoid Arthritis from the GISEA Regist…

2012

Objective.To evaluate 4-year retention rates of tumor necrosis factor-α (TNF-α) inhibitors adalimumab, etanercept, and infliximab among patients with longstanding rheumatoid arthritis (RA), as derived from an Italian national registry.Methods.The clinical records of 853 adult patients with RA in the GISEA (Gruppo Italiano Studio Early Arthritis) registry were prospectively analyzed to compare drug survival rates and the baseline factors that may predict adherence to therapy.Results.In 2003 and 2004, 324 patients started treatment with adalimumab, 311 with etanercept, and 218 with infliximab. After 4 years, the global retention rate of anti-TNF-α therapy was 42%. Etanercept survival (51.4%) …

MaleTime FactorsHealth StatusArthritisKaplan-Meier EstimateReceptors Tumor Necrosis FactorEtanerceptlaw.inventionEtanerceptArthritis RheumatoidRandomized controlled triallawRheumatoidMonoclonalReceptorsImmunology and AllergyProspective StudiesRegistriesskin and connective tissue diseasesProspective cohort studyHumanizedAntibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthralgia; Arthritis Rheumatoid; Biological Markers; Drug Substitution; Female; Health Status; Humans; Immunoglobulin G; Italy; Joints; Kaplan-Meier Estimate; Male; Middle Aged; Pain Measurement; Prospective Studies; Receptors Tumor Necrosis Factor; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; RegistriesPain MeasurementDrug SubstitutionAntibodies MonoclonalMiddle AgedArthralgiaAdalimumab; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthralgia; Arthritis Rheumatoid; Biomarkers; Drug Substitution; Etanercept; Female; Health Status; Humans; Immunoglobulin G; Infliximab; Italy; Joints; Kaplan-Meier Estimate; Male; Middle Aged; Pain Measurement; Prospective Studies; Receptors Tumor Necrosis Factor; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; RegistriesSurvival RateItalyRheumatoid arthritisAntirheumatic AgentsBiological MarkersAdalimumab; Drug survival; Etanercept; Infliximab; Adalimumab; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Antirheumatic Agents; Arthralgia; Arthritis Rheumatoid; Biomarkers; Drug Substitution; Etanercept; Female; Health Status; Humans; Immunoglobulin G; Infliximab; Italy; Joints; Kaplan-Meier Estimate; Male; Middle Aged; Pain Measurement; Prospective Studies; Receptors Tumor Necrosis Factor; Survival Rate; Time Factors; Tumor Necrosis Factor-alpha; Registries; Rheumatology; Immunology; Immunology and AllergyFemalemedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyImmunologyAntibodies Monoclonal HumanizedAntibodiesRheumatologyDrug survivalInternal medicineAdalimumabmedicineHumansSurvival ratebusiness.industryTumor Necrosis Factor-alphaArthritisAdalimumabmedicine.diseaseInfliximabInfliximabSurgeryImmunoglobulin GJointsbusinessTumor Necrosis FactorBiomarkers
researchProduct

Bone mineral density of the proximal femur after hip resurfacing arthroplasty: 1-year follow-up study

2011

Abstract Background Hip resurfacing arthroplasty (HRA) is considered a bone-preserving procedure and may eliminate proximal femoral stress shielding and osteolysis. However, in addition to implant-related stress-shielding factors, various patient-related factors may also have an effect on bone mineral density (BMD) of the proximal femur in patients with HRA. Thus, we studied the effects of stem-neck angle, demographic variables, and physical functioning on the BMD of the proximal femur in a one-year follow-up. Methods Thirty three patients (9 females and 24 males) with a mean (SD) age of 55 (9) years were included in the study. BMD was measured two days and 3, 6, and 12 months postoperative…

MaleTime Factorslcsh:Diseases of the musculoskeletal systemBone densityArthroplasty Replacement Hipmedicine.medical_treatmentdual energy X-ray absorptiometry02 engineering and technologySeverity of Illness IndexOsteoarthritis HipAbsorptiometry Photon0302 clinical medicineBone DensityOrthopedics and Sports MedicineFemurProspective StudiesFinlandstress shielding2. Zero hungerBone mineral030222 orthopedicsmedicine.diagnostic_teststem-neck angleMiddle AgedStress shieldingHip resurfacingREPLACEMENTTreatment Outcomemedicine.anatomical_structureFemaleResearch Articlebone remodeling dual energy X-ray absorptiometrymusculoskeletal diseasesmedicine.medical_specialtyeducation0206 medical engineering03 medical and health sciencesFemoral headPOSTERIOR APPROACHRheumatologymedicineHumansFemurPRESERVATIONbone remodelingNECKDual-energy X-ray absorptiometrybusiness.industry3126 Surgery anesthesiology intensive care radiology020601 biomedical engineeringArthroplastySurgeryLogistic Models5-YEARMODESABSORPTIOMETRYFEMORAL-HEADlcsh:RC925-935businessNuclear medicineFollow-Up StudiesBMC Musculoskeletal Disorders
researchProduct